内皮血管活性通路和脏结果:一种药物向的门德尔随机化和转录组范围的协会研究
Yixin Ma1, Lubin Xu1, Yitao Lin1
1Department of Nephrology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Kidney diseases (Basel, Switzerland)
|December 1, 2025
概括
基因决定的内皮血管活性通路显著影响功能,显示出更高的估计膜过率 (eGFR) 和降低慢性病 (CKD) 风险. 这些发现表明脏疾病的潜在新治疗点.
科学领域:
- 血管生物学 血管生物学
- 腎臟病學 (nephrology) 是一種醫學.
- 遗传学 是一个遗传学.
背景情况:
- 由内皮介导的血管度对于功能至关重要.
- 向内甲蛋白轴在脏疾病中表现有前途,但长期影响尚未得到充分研究.
- 像门德尔随机化 (MR) 和转录组宽关联研究 (TWAS) 这样的遗传方法可以探索血管活性通路对结局的终身影响.
研究的目的:
- 研究内皮血管活性通路的遗传决定变异对功能和疾病的终身影响.
- 利用MR和TWAS模仿自然随机对照试验来评估脏结果.
主要方法:
- 从全基因组关联研究 (GWASs) 提取的总结统计数据.
- 使用逆方差加权 (IVW) 方法进行MR分析与灵敏度分析.
- 使用S-PrediXcan进行TWAS分析.
主要成果:
- 基因预测的eNOS通路激活与更高的eGFR相关,降低了CKD风险,以及较慢的功能下降.
- TWAS证实了eNOS通路基因表达与eGFR之间的积极关联.
- 总体而言,内皮血管活性效应与改善的EGFR显著相关.
结论:
- 内皮血管活性通路显著影响与脏相关的结果.
- 这些途径代表了慢性病 (CKD) 新型治疗策略的有希望的目标.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
485
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
485
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
Renal Drug Excretion: Overview
620
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
620
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Renal Drug Clearance: Overview
639
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
639


